Amneal Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AMRX and other ETFs, options, and stocks.

About AMRX

Amneal Pharmaceuticals, Inc. is a medicine company, which engages in the provision of pharmaceuticals. Its product portfolio includes generics, specialty, biosciences, and product catalog. 

CEO
Chintu Patel
CEOChintu Patel
Employees
8,300
Employees8,300
Headquarters
Bridgewater, New Jersey
HeadquartersBridgewater, New Jersey
Founded
2002
Founded2002
Employees
8,300
Employees8,300

AMRX Key Statistics

Market cap
2.57B
Market cap2.57B
Price-Earnings ratio
1.18K
Price-Earnings ratio1.18K
Dividend yield
Dividend yield
Average volume
1.53M
Average volume1.53M
High today
$8.21
High today$8.21
Low today
$8.01
Low today$8.01
Open price
$8.04
Open price$8.04
Volume
1.16M
Volume1.16M
52 Week high
$9.48
52 Week high$9.48
52 Week low
$6.69
52 Week low$6.69

AMRX News

Seeking Alpha 2d
Amneal raises 2025 guidance and targets $300M–$500M peak CREXONT sales as new launches accelerate

Earnings Call Insights Amneal raises 2025 guidance and targets $300M–$500M peak CREXONT sales as new launches accelerate Aug. 05, 2025 2:57 PM ET Amneal Pharmac...

Amneal raises 2025 guidance and targets $300M–$500M peak CREXONT sales as new launches accelerate
Seeking Alpha 3d
Amneal Pharmaceuticals Non-GAAP EPS of $0.25 beats by $0.08, revenue of $725M misses by $19.56M

Earnings News Amneal Pharmaceuticals Non-GAAP EPS of $0.25 beats by $0.08, revenue of $725M misses by $19.56M Aug. 05, 2025 6:08 AM ET Amneal Pharmaceuticals, I...

Amneal Pharmaceuticals Non-GAAP EPS of $0.25 beats by $0.08, revenue of $725M misses by $19.56M

People also own

Based on the portfolios of people who own AMRX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.